Purpose: To report the successful use of tofacitinib in the treatment of refractory uveitis and scleritis.
Observations: Two patients, one with scleritis and another with anterior and intermediate uveitis, presented with refractory disease after failure of multiple steroid-sparing therapies. Treatment with tofacitinib led to durable resolution of uveitis and scleritis.
Conclusions And Importance: Tofacitinib is a potential novel treatment option for refractory, noninfectious inflammatory eye disease.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6288302 | PMC |
| http://dx.doi.org/10.1016/j.ajoc.2018.12.001 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Comparative Study of Adalimumab, Infliximab and Certolizumab Pegol in the Treatment of Cystoid Macular Edema Due to Behçet's Disease.
J Clin Med
December 2024
Immunopathology Group, Marqués de Valdecilla University Hospital, Instituto de Investigación Valdecilla (IDIVAL), 39011 Santander, Spain.
The leading cause of blindness due to non-infectious uveitis is cystoid macular edema (CME). Behçet's disease (BD) is one of the most commonly conditions related to CME. To compare the effectiveness and safety of adalimumab (ADA), infliximab (IFX) and certolizumab (CZP) in refractory CME due to BD.
View Article and Find Full Text PDFPseudomonas-induced scleritis mimicking autoimmune necrotizing scleritis. A case report.
Arch Soc Esp Oftalmol (Engl Ed)
December 2024
Departamento de Uveítis e Inmunología Ocular, Instituto de Oftalmología FAP Conde de Valenciana, Mexico City, Mexico. Electronic address:
To report a case of spontaneous-onset unilateral scleritis and keratitis due to Pseudomonas aeruginosa in a patient with systemic lupus erythematosus who partially responded to antibiotic therapy and achieved complete resolution after IV immunotherapy. A 30-year-old woman with a past medical history of hypothyroidism and systemic lupus erythematosus and on irregular therapy presented with a long-history of thinning of the sclera and cornea refractory to antibiotic therapy despite a positive culture for P. aeruginosa, which eventually resolved with the implementation of immunotherapy.
View Article and Find Full Text PDFCyclosporin A as an adjunct may enhance the therapeutic effect of interferon alpha-2a in patients with refractory Behcet's uveitis: a retrospective cohort study.
Ther Adv Chronic Dis
December 2024
The First Affiliated Hospital of Chongqing Medical University, Chongqing Branch (Municipality Division) of National Clinical Research Center for Ocular Diseases, Chongqing, China.
Background: The application of biologic agents has benefited patients with Behcet's uveitis (BU) who do not respond to conventional treatment regimens. However, there is currently no consensus on the optimal treatment regimen of interferon alpha-2a (IFN-α2a) for refractory BU.
Objectives: To evaluate treatment outcomes and safety of IFN-α2a in a large series of refractory BU patients and to explore whether nonbiologic immunomodulatory agents (cyclosporin A) other than corticosteroids should be concomitantly used.
Application of allogeneic hematopoietic stem cell transplantation to treat Behcet's disease with myelodysplastic syndrome: a case report and literature review.
Ann Hematol
December 2024
Division of Hematology, Department of Medicine, The First Affiliated Hospital of Harbin Medical University, 23 Youzheng Street, Nan Gang District, Harbin, 150001, Heilongjiang Province, China.
Trisomy 8 is a frequent chromosomal abnormality that occurs among patients with myelodysplastic syndrome (MDS). This abnormality is more common among MDS patients with concurrent Behcet's disease (BD) than among patients with MDS alone. This comorbidity is also associated with a higher prevalence of intestinal ulcers.
View Article and Find Full Text PDFCBL syndrome presenting with severe EBV infection and panuveitis masquerade.
Eur J Ophthalmol
November 2024
Department of Ophthalmology, IHU FOReSIGHT, Hôpital Universitaire Pitié-Salpêtrière, Sorbonne Université, Paris, France.
Article Synopsis
- This case report discusses a 35-month-old boy with CBL syndrome who experienced life-threatening Epstein-Barr virus (EBV) infections and rod-cone dystrophy (RCD) that appeared similar to severe panuveitis.
- Genetic testing indicated a pathogenic variant related to CBL syndrome, leading to complications including encephalitis and severe eye inflammation.
- The report emphasizes the importance of considering RCD in CBL syndrome patients with unexplained eye inflammation and suggests using carbonic anhydrase inhibitors as a treatment for cystoid macular edema.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!